DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Moreno C, Greil R, Demirkan F. et al.
Ibrutinib + Obinutuzumab Versus Chlorambucil + Obinutuzumab As First-Line Treatment in Patients with Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma (CLL/SLL): Results from Phase 3 iLLUMINATE.
Blood 2018;
132: 691
We do not assume any responsibility for the contents of the web pages of other providers.